This synergism may support the combination of eravacycline with aztreonam/avibactam to suppress resistance emergence.10 Animal data demonstrated synergistic bactericidal activity of the combination of eravacycline with aztreonam/avibactam in a murine subcutaneous abscess model caused by NDM-Kp. The gene discussed is NPPA; the disease is abscess.